Hhm Wealth Advisors, LLC Amgen Inc Transaction History

Hhm Wealth Advisors, LLC

$697 Million
Q3 2024

A detailed history of Hhm Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hhm Wealth Advisors, LLC holds 1,208 shares of AMGN stock, worth $319,503. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,208

Previous 1,208 -0.0%

Holding current value

$319,503

Previous $377,000 3.18%

% of portfolio

0.06%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $7,094 - $8,621	-27 Reduced 2.19%	1,208 $377,000
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $23,391 - $28,236	-87 Reduced 6.58%	1,235 $351,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $2,142 - $2,533	-10 Reduced 0.75%	1,322 $293,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $39,513 - $48,160	-175 Reduced 11.61%	1,332 $322,000
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $2,290 - $2,910	10 Added 0.67%	1,507 $0
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $84,172 - $94,931	-375 Reduced 20.03%	1,497 $337,000
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $8,536 - $9,499	37 Added 2.02%	1,872 $455,000
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $43,355 - $49,616	-218 Reduced 10.62%	1,835 $413,000
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $58,374 - $68,392	275 Added 15.47%	2,053 $437,000
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $4,905 - $5,441	21 Added 1.2%	1,778 $433,000
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $82,873 - $98,687	383 Added 27.87%	1,757 $404,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $125,537 - $139,608	535 Added 63.77%	1,374 $349,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $5,340 - $6,553	27 Added 3.33%	839 $198,000
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $147,978 - $196,260	812 New	812 $165,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.

Account

Hhm Wealth Advisors, LLC Amgen Inc Transaction History